ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons.

Chakrapani Balijepalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.